Prediabetes is a serious health condition where blood sugar levels are higher than usual, but not high enough yet for a type 2 diabetes diagnosis. According to Diabetes UK, at

The Sunday Times reported on the 6 February 2022 that a new blood testing technique due to be introduced by the NHS will determine how likely a patient is to

Goodbody Health Inc (CSE:GDBY / AQSE:GDBY / FRA: 484 / OTC: SCNNF)has announced today its subsidiary Phytovista Laboratories has achieved another significant milestone with an extension to its ISO 17025 UKAS accreditation with

We’re on the verge of the biggest shake-up of the UK’s consumer health sector in relation to cannabinoid products (CBD).  The Association for the Cannabinoid Industry (ACI) announced in a

The Board of The National Institute for Health and Care Excellence (NICE), provided an update on 20 January 2022 on how it plans to evaluate promising new health technologies and

Goodbody Health Inc. (AQSE: GDBY) has announced that further to the Company’s announcement on 10 January 2022, announcing the change of the Company’s name to Goodbody Health Inc., the Company’s ISIN